Sensei Biotherapeutics financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

USD	FY, 2018	FY, 2019	FY, 2021
General and administrative expense	4.5M	4.1M	15.8M
Operating expense total	12.7M	12.4M
EBIT	(12.7M)	(12.4M)	(37.5M)
Investment income			800.0K
Interest expense	327.0K	2.3M
Income tax expense			(8.3M)
Net Income	(13.0M)	(16.7M)	(36.8M)
EPS	(45.9)	(55.9)

Footer menu